, buoyed by a huge jump in sales for its COVID-19 vaccine and solid first-quarter performance across most of the company, hiked its 2021 financial forecast after sharply after blowing past Wall Street expectations.
“Investors were skeptical of the Wyeth acquisition because vaccines were a sleepy area with lots of risk and rarely enough profit to justify spending money on them.Pfizer , which splits vaccine costs and profit with BioNTech, reported $3.46 billion in first-quarter sales in all but three countries; BioNTech will report the remaining revenue on May 10.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
EU agrees potential 1.8 billion-dose purchase of Pfizer jabThe European Union cemented its support for Pfizer-BioNTech and its novel COVID-19 vaccine technology Saturday by agreeing to a massive contract extension for a potential 1.8 billion doses through 2023. We now take you live on scene at vaccination clinics in Quebec Canada.
Source: CTVNews - 🏆 1. / 99 Read more »
Pfizer Canada vaccine lead says lifting patents isn’t solution to inequityThe vaccine lead for Pfizer Canada says temporarily waiving intellectual property rights and patents isn’t the solution to COVID-19 vaccine inequity. No, but it's a start. Also, it creates long-term objective not to attend too much on research. Politicians don't know what they're doing.
Source: CTVNews - 🏆 1. / 99 Read more »
Pfizer/BioNTech jab confirmed to protect 95 per cent in largest study yetThe largest real-world study yet of the Pfizer/BioNTech vaccine on Thursday confirmed that the jab provided more than 95 per cent protection against COVID-19, but found that the level dropped significantly when people received just one of the two prescribed doses. Comparing vaccines: country of origin, safety, price, efficacy, and approval Pfizer, Johnson & Johnson, Moderna, AstraZeneca, Sputnik V, Sinopharm, Bharat Biotech (COVAXIN), Medicago (CoVLP) All the more reason to advance the timelines of the 2nd shot in Canada. Other study now shows only 30% after only 1st shot against variants. Ahhhh science..........and results
Source: CTVNews - 🏆 1. / 99 Read more »
Pfizer and BioNTech to donate vaccines for Olympic athletesVaccine developers Pfizer and BioNTech will donate doses to inoculate athletes and officials preparing for the Tokyo Olympics, the IOC said Thursday. Really? Priorities. How noble. Good investment.
Source: CTVNews - 🏆 1. / 99 Read more »